9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (44%) |
| §112 only | 2 (22%) |
| Double-patenting only | 1 (11%) |
| Double-patenting + other | 1 (11%) |
| No statute on record | 1 (11%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLEMAN, BRENDA LIBBY | 1 | 74.7% | +15.5% |
| COUGHLIN, MATTHEW P | 1 | 71.4% | +11.9% |
| SHIM, DAVID M. | 1 | 58.0% | +55.9% |
| HUI, SAN MING R | 1 | 59.2% | +19.9% |
| ELENISTE, PIERRE PAUL | 1 | 36.9% | +31.6% |
| BORALSKY, LUKE ALAN | 1 | 100.0% | +0.0% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.6% | +18.3% |
| HEES, OLIVER DRAGON | 1 | 100.0% | +0.0% |
| RODRIGUEZ, RAYNA B | 1 | 33.0% | +20.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18263189 | USE OF NEUROACTIVE STEROIDS FOR TREATMENT OF SEXUAL DYSFUNCTION | BORALSKY, LUKE ALAN | — |
| 17416367 | 3.ALPHA.-HYDROXY-17.BETA.-AMIDE NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF | HEES, OLIVER DRAGON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17579541 | FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF | CHANDRAKUMAR, NIZAL S | 124d overdue |
| 18550724 | A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER | ELENISTE, PIERRE PAUL | 42d overdue |
| 18557691 | 19-NOR C3,3-DISUBSTITUTED C21 -N-PYRAZOLYL STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION | SHIM, DAVID M. | 22d |
| 18741425 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | COLEMAN, BRENDA LIBBY | — |
| 18636563 | C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE | COUGHLIN, MATTHEW P | — |
| 18473702 | COMPOUNDS FOR TREATING CNS DISORDERS | HUI, SAN MING R | — |
| 16955714 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | RODRIGUEZ, RAYNA B | — |
| Art Unit | Apps |
|---|---|
| 1628 | 2 |
| 1626 | 1 |
| 1627 | 1 |
| 1622 | 1 |
| 1624 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18741425 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | COLEMAN, BRENDA LIBBY | — | §112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18636563 | C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE | COUGHLIN, MATTHEW P | — | §112 | Non-Final OA | — | Pending | Apr 16, 2024 |
| 18557691 | 19-NOR C3,3-DISUBSTITUTED C21 -N-PYRAZOLYL STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION | SHIM, DAVID M. | 1626 | §103 | Non-Final OA | 22d | Pending | Oct 27, 2023 |
| 18473702 | COMPOUNDS FOR TREATING CNS DISORDERS | HUI, SAN MING R | 1627 | §103 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18550724 | A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER | ELENISTE, PIERRE PAUL | 1622 | Other | Non-Final OA | 42d overdue | Pending | Sep 15, 2023 |
| 18263189 | USE OF NEUROACTIVE STEROIDS FOR TREATMENT OF SEXUAL DYSFUNCTION | BORALSKY, LUKE ALAN | 1624 | DPOther | Non-Final OA | — | Pending | Jul 27, 2023 |
| 17579541 | FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Final Rejection | 124d overdue | Pending | Jan 19, 2022 |
| 17416367 | 3.ALPHA.-HYDROXY-17.BETA.-AMIDE NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF | HEES, OLIVER DRAGON | 1628 | §103 | Final Rejection | — | Pending | Jun 18, 2021 |
| 16955714 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | RODRIGUEZ, RAYNA B | 1628 | DP | Final Rejection | — | Pending | May 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial